Clinical Trials in Oncology: Key Points to Consider
Cancer is a major cause of death and reduced life expectancy. As per GLOBOCAN reports, in 2020, there were around 19.3 million new cancer cases worldwide, and 10 million people died due to cancer. New cancer cases are estimated to increase to 28.4 million by 2040 – a 47% increase from 2020. These are not just numbers but real human cases – the development of new drugs and treatment regimens for reducing the global disease burden is essential.
Understanding the challenges at all stages is important to carve out solutions and ensure clinical trial success. This article will discuss the key points to consider when conducting oncology clinical trials.